Common use of Perpetual, Royalty-Free Non-Exclusive License Clause in Contracts

Perpetual, Royalty-Free Non-Exclusive License. If Biogen has exercised its Option for a particular Collaboration Program, then upon expiration of the Reduced Royalty Period in all countries in which the applicable Products are being or have been sold, Ionis will and hereby does grant to Biogen a perpetual, nonexclusive, worldwide, royalty-free, fully paid-up, sublicensable license under the Ionis Know-How to Manufacture, Develop and Commercialize any Product under such Collaboration Program.

Perpetual, Royalty-Free Non-Exclusive License. If Biogen has exercised its Option been granted a license under Section 4.1.1 for a particular Collaboration ProgramProduct, then upon expiration of the Reduced Royalty Period for such Product in all countries in which the applicable Products are such Product is being or have has been sold, Ionis will and hereby does grant to Biogen a perpetual, nonexclusivenon-exclusive, worldwide, royalty-free, fully paid-up, sublicensable license under the Ionis Know-How to Manufacture, Develop and Commercialize any Product under such Collaboration Programthe applicable Product.

Perpetual, Royalty-Free Non-Exclusive License. If Biogen has exercised its Option been granted a license under Section 4.1.1(a) or Section 4.1.1(b) (as applicable) for a particular Collaboration ProgramProduct, then upon expiration of the Biogen Alternate Modality Royalty Period or Reduced Royalty Period Period, as the case may be, in all countries in which the applicable Products are being or have been sold, Ionis will and hereby does grant to Biogen a perpetual, nonexclusivenon-exclusive, worldwide, royalty-free, fully paid-up, sublicensable license under the Ionis Know-How to Manufacture, Develop and Commercialize any Product under such Collaboration Programthe applicable Product. 10.4.3.

Perpetual, Royalty-Free Non-Exclusive License. If Biogen has exercised its Option been granted a license under Section 4.1.1(a) or Section 4.1.1(b) (as applicable) for a particular Collaboration ProgramProduct, then upon expiration of the Biogen Alternate Modality Royalty Period or Reduced Royalty Period Period, as the case may be, in all countries in which the applicable Products are being or have been sold, Ionis will and hereby does grant to Biogen a perpetual, nonexclusivenon-exclusive, worldwide, royalty-free, fully paid-up, sublicensable license under the Ionis Know-How to Manufacture, Develop and Commercialize any Product under such Collaboration Programthe applicable Product.